PUS — Pulsion Medical Systems SE Income Statement
0.000.00%
HealthcareAdventurousSmall Cap
- €174.79m
- €187.52m
- €39.99m
Annual income statement for Pulsion Medical Systems SE, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 32.1 | 28 | 29.7 | 35.8 | 40 |
Cost of Revenue | |||||
Gross Profit | 18.9 | 14.8 | 15.3 | 12.4 | 24.2 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 22.4 | 21.8 | 22.3 | 31 | 24.8 |
Operating Profit | 9.65 | 6.12 | 7.39 | 4.75 | 15.2 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 9.78 | 6.17 | 7.42 | 5.02 | 15.5 |
Provision for Income Taxes | |||||
Net Income After Taxes | 9.45 | 5.93 | 7.19 | 5.03 | 15.5 |
Net Income Before Extraordinary Items | |||||
Net Income | 9.45 | 5.93 | 7.19 | 5.03 | 15.5 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 0.122 | 1.07 | 0.988 | -2.95 | 0.545 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.015 | 0.13 | 0.12 | -0.358 | 0.066 |
Dividends per Share |